Here, we report that PSMD1 and PSMD3 promote NF-κB protein expression and transcriptional activity in CML, and that STAT3 perpetuates this signal in scenarios of TKI resistance. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.